Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks

DNA Repair

Volumn 5, Issue 9-10, 2006, Pages 1199-1212

  Povirk, Lawrence F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bleomycin; End joining; Phosphoglycolate; Radiation

Indexed keywords

AMSACRINE; APURINIC ACID; BLEOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOUBLE STRANDED DNA; GYRASE INHIBITOR; MITOXANTRONE; POLYNUCLEOTIDE 5' HYDROXYL KINASE; ZINOSTATIN;

ACUTE GRANULOCYTIC LEUKEMIA; APYRIMIDINIC SITE; ARTICLE; AUTOPHOSPHORYLATION; CANCER COMBINATION CHEMOTHERAPY; CHERNOBYL ACCIDENT; CHO CELL; CHROMOSOME BREAKAGE; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 15; CROSSING OVER; DNA REPAIR; DNA SEQUENCE; DNA STRAND BREAKAGE; ENZYME INHIBITION; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE SEQUENCE; HUMAN; MOLECULAR RECOGNITION; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION CARCINOGENESIS; RADIATION INJURY; RADIATION MUTAGENESIS; THYROID CARCINOMA;

ANIMALS; BASE SEQUENCE; CHO CELLS; CHROMOSOME BREAKAGE; CRICETINAE; DNA DAMAGE; DNA REPAIR ENZYMES; MOLECULAR SEQUENCE DATA; RADIATION, IONIZING; RECOMBINATION, GENETIC; THYROID NEOPLASMS; TRANSLOCATION, GENETIC;

MAMMALIA;

EID: 33747888767     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.05.016     Document Type: Article

References (113)

1. Lea D.E. Actions of Radiations on Living Cells (1946), Cambridge University Press, Cambridge
2. Bender M.A., Griggs H.G., and Bedford J.S. Mechanisms of chromosomal aberration production 3. Chemicals and ionizing radiation. Mutat. Res. 23 (1974) 197-212
3. Tewey K.M., Chen G.L., Nelson E.M., and Liu L.F. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259 (1984) 9182-9187
4. Corbett A.H., and Osheroff N. When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. Chem. Res. Toxicol. 6 (1993) 585-597
5. Anderson R.D., and Berger N.A. International commission for protection against environmental mutagens and carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat. Res. 309 (1994) 109-142
6. Albain K.S., LeBeau M.M., Ullirsch R., and Schumacher H. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9; 11 translocation. Genes Chromosomes Cancer 2 (1990) 53-58
7. Ahuja H.G., Felix C.A., and Aplan P.D. Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations. Genes Chromosomes Cancer 29 (2000) 96-105
8. Lovett B.D., Lo Nigro L., Rappaport E.F., Blair I.A., Osheroff N., Zheng N., Megonigal M.D., Williams W.R., Nowell P.C., and Felix C.A. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9802-9807
9. Langer T., Metzler M., Reinhardt D., Viehmann S., Borkhardt A., Reichel M., Stanulla M., Schrappe M., Creutzig U., Ritter J., Leis T., Jacobs U., Harbott J., Beck J.D., Rascher W., and Repp R. Analysis of t(9;1 1) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chromosomes Cancer 36 (2003) 393-401
10. Whitmarsh R.J., Saginario C., Zhuo Y., Hilgenfeld E., Rappaport E.F., Megonigal M.D., Carroll M., Liu M., Osheroff N., Cheung N.K., Slater D.J., Ried T., Knutsen T., Blair I.A., and Felix C.A. Reciprocal DNA topoisomerase II cleavage events at 5′-TATTA-3′ sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing. Oncogene 22 (2003) 8448-8459
11. Mistry A.R., Felix C.A., Whitmarsh R.J., Mason A., Reiter A., Cassinat B., Parry A., Walz C., Wiemels J.L., Segal M.R., Ades L., Blair I.A., Osheroff N., Peniket A.J., Lafage-Pochitaloff M., Cross N.C., Chomienne C., Solomon E., Fenaux P., and Grimwade D. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med. 352 (2005) 1529-1538
12. Reichel M., Gillert E., Breitenlohner I., Repp R., Greil J., Beck J.D., Fey G.H., and Marschalek R. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research. Cancer Res. 59 (1999) 3357-3362
13. Super H.G., Strissel P.L., Sobulo O.M., Burian D., Reshmi S.C., Roe B., Zeleznik-Le N.J., Diaz M.O., and Rowley J.D. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer 20 (1997) 185-195
14. Gale K.C., and Osheroff N. Intrinsic intermolecular DNA ligation activity of eukaryotic topoisomerase II. Potential roles in recombination. J. Biol. Chem. 267 (1992) 12090-12097
15. Bae Y.S., Kawasaki I., Ikeda H., and Liu L.F. Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2076-2080
16. Zhou R.-H., Wang P., Zou Y., Jackson-Cook C.K., and Povirk L.F. A precise interchromosomal reciprocal exchange between hotspots for cleavable complex formation by topoisomerase II in amsacrine-treated CHO cells. Cancer Res. 57 (1997) 4699-4702
17. Nikiforov Y.E., Rowland J.M., Bove K.E., Monforte-Munoz H., and Fagin J.A. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 57 (1997) 1690-1694
18. Bongarzone I., Butti M.G., Fugazzola L., Pacini F., Pinchera A., Vorontsova T.V., Demidchik E.P., and Pierotti M.A. Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics 42 (1997) 252-259
19. Nikiforov Y.E., Koshoffer A., Nikiforova M., Stringer J., and Fagin J.A. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene 18 (1999) 6330-6334
20. Gandhi M., Medvedovic M., Stringer J.R., and Nikiforov Y.E. Interphase chromosome folding determines spatial proximity of genes participating in carcinogenic RET/PTC rearrangements. Oncogene 25 (2006) 2360-2366
21. Dedon P.C., and Goldberg I.H. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem. Res. Toxicol. 5 (1992) 311-332
22. Povirk L.F. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutat. Res. 355 (1996) 71-89
23. Wang P., Zhou R.-H., Zou Y., Jackson-Cook C.K., and Povirk L.F. Highly conservative reciprocal translocations formed by apparent joining of exchanged DNA double-strand break ends. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12018-12023
24. Wang P., Lee J.W., Turner K., Zou Y., Jackson-Cook C.K., and Povirk L.F. Rearrangements induced by the DNA double-strand cleaving agent neocarzinostatin: conservative nonhomologous reciprocal exchanges in an otherwise stable genome. Nucleic Acids Res. 30 (2002) 2639-2646
25. Povirk L.F. A highly conservative, cyclically permuted, non-homologous exchange among three unrelated DNA sequences in bleomycin-treated CHO cells. Int. J. Radiat. Biol. 74 (1998) 561-564
26. Sankaranarayanan K. Ionizing radiation and genetic risks. III. Nature of spontaneous and radiation-induced mutations in mammalian in vitro systems and mechanisms of induction of mutations by radiation. Mutat. Res. 258 (1991) 75-97
27. Fuscoe J.C., Zimmerman L.J., Fekete A., Setzer R.W., and Rossiter B.J. Analysis of X-ray-induced HPRT mutations in CHO cells: insertion and deletions. Mutat. Res. 269 (1992) 171-183
28. Little J.B. Cellular, molecular, and carcinogenic effects of radiation. Hematol. Oncol. Clin. North Am. 7 (1993) 337-352
29. Schwartz J.L., Rotmensch J., Sun J., An J., Xu Z., Yu Y., and Hsie A.W. Multiplex polymerase chain reaction-based deletion analysis of spontaneous, gamma ray- and alpha-induced hprt mutants of CHO-K1 cells. Mutagenesis 9 (1994) 537-540
30. Morris T., and Thacker J. Formation of large deletions by illegitimate recombination in the HPRT gene of primary human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1392-1396
31. Miles C., Sargent G., Phear G., and Meuth M. DNA sequence analysis of gamma radiation-induced deletions and insertions at the APRT locus of hamster cells. Mol. Carcinog. 3 (1990) 233-242
32. Yu Y., Inamdar K.V., Turner K., Jackson-Cook C.K., and Povirk L.F. Base substitutions, targeted single-base deletions and reciprocal translocations induced by bleomycin in plateau-phase mammary epithelial cells. Radiat. Res. 158 (2002) 327-338
33. Jordan R., and Schwartz J.L. Noninvolvement of the X chromosome in radiation-induced chromosome translocations in the human lymphoblastoid cell line TK6. Radiat. Res. 137 (1994) 290-294
34. Seabright M. Noninvolvement of the human X chromosome in X-ray induced exchanges. Cytogenet. Cell Genet. 12 (1973) 342-356
35. Zhou T., and Povirk L.F. Extreme cytotoxicity and susceptibility to hprt mutagenesis in Ku-deficient xrs-6 cells treated with bleomycin in plateau phase. Mutagenesis 20 (2005) 39-44
36. Singleton B.K., Griffin C.S., and Thacker J. Clustered DNA damage leads to complex genetic changes in irradiated human cells. Cancer Res. 62 (2002) 6263-6269
37. Simpson P., Morris T., Savage J., and Thacker J. High-resolution cytogenetic analysis of X-ray induced mutations of the HPRT gene of primary human fibroblasts. Cytogenet. Cell Genet. 64 (1993) 39-45
38. Lukacsovich T., Yang D., and Waldman A.S. Repair of a specific double-strand break generated within a mammalian chromosome by yeast endonuclease I-SceI. Nucleic Acids Res. 22 (1994) 5649-5657
39. Anglana M., and Bacchetti S. Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres. Nucleic Acids Res. 27 (1999) 4276-4281
40. Richardson C., and Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405 (2000) 697-700
41. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., and Lopez B.S. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol. Cell 14 (2004) 611-623
42. Sandor Z., Calicchio M.L., Sargent R.G., Roth D.B., and Wilson J.H. Distinct requirements for Ku in N nucleotide addition at V(D)J-and non-V(D)J-generated double-strand breaks. Nucleic Acids Res. 32 (2004) 1866-1873
43. Weinstock D.M., Elliott B., and Jasin M. A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 107 (2006) 777-780
44. Elliott B., Richardson C., and Jasin M. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol. Cell 17 (2005) 885-894
45. van Heemst D., Brugmans L., Verkaik N.S., and van Gent D.C. End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. DNA Repair 3 (2004) 43-50
46. Lutze L.H., Cleaver J.E., Morgan W.F., and Winegar R.A. Mechanisms involved in rejoining DNA double-strand breaks induced by ionizing radiation and restriction enzymes. Mutat. Res. 299 (1993) 225-232
47. Povirk L.F., Bennett R.A.O., Wang P., Swerdlow P.S., and Austin M.J.F. Single base-pair deletions induced by bleomycin at potential double-strand cleavage sites in the aprt gene of stationary phase Chinese hamster ovary D422 cells. J. Mol. Biol. 243 (1994) 216-226
48. Richardson C., Moynahan M.E., and Jasin M. Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations. Genes Dev. 12 (1998) 3831-3842
49. Thode S., Schafer A., Pfeiffer P., and Vielmetter W. A novel pathway of DNA end-to-end joining. Cell 60 (1990) 921-928
50. Pfeiffer P., Thode S., Hancke J., and Vielmetter W. Mechanisms of overlap formation in nonhomologous DNA end joining. Mol. Cell. Biol. 14 (1994) 888-895
51. Pfeiffer P., Thode S., Hancke J., Keohavong P., and Thilly W.G. Resolution and conservation of mismatches in DNA end joining. Mutagenesis 9 (1994) 527-535
52. Feldmann E., Schmiemann V., Goedecke W., Reichenberger S., and Pfeiffer P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 28 (2000) 2585-2596
53. Chen S., Inamdar K.V., Pfeiffer P., Feldmann E., Hannah M.F., Yu Y., Lee J.W., Zhou T., Lees-Miller S.P., and Povirk L.F. Accurate in vitro end-joining of a DNA double-strand break with partially cohesive 3′-overhangs and 3′-phosphoglycolate termini: effect of Ku on repair fidelity. J. Biol. Chem. 276 (2001) 24323-24330
54. Lee J.W., Yannone S.M., Chen D.J., and Povirk L.F. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro. Cancer Res. 63 (2003) 22-24
55. Lee J.W., Blanco L., Zhou T., Bebenek K., Garcia-Diaz M., Kunkel T.A., Wang Z., and Povirk L.F. Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts. J. Biol. Chem. 279 (2004) 805-811
56. Mahajan K.N., Nick McElhinny S.A., Mitchell B.S., and Ramsden D.A. Association of DNA polymerase mu (polμ) with Ku and ligase IV: role for polμ in end-joining double-strand break repair. Mol. Cell. Biol. 22 (2002) 5194-5202
57. Nick McElhinny S.A., Havener J.M., Garcia-Diaz M., Juarez R., Bebenek K., Kee B.L., Blanco L., Kunkel T.A., and Ramsden D.A. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol. Cell 19 (2005) 357-366
58. Ma Y., Lu H., Tippin B., Goodman M.F., Shimazaki N., Koiwai O., Hsieh C.L., Schwarz K., and Lieber M.R. A biochemically defined system for mammalian nonhomologous DNA end joining. Mol. Cell 16 (2004) 701-713
59. Pfeiffer P., and Vielmetter W. Joining of nonhomologous DNA double strand breaks in vitro. Nucleic Acids Res. 16 (1988) 907-924
60. Gu X.-Y., Bennett R.A.O., and Povirk L.F. End-joining of free radical-mediated DNA double-strand breaks in vitro is blocked by the kinase inhibitor wortmannin at a step preceding removal of damaged 3′ termini. J. Biol. Chem. 271 (1996) 19660-19663
61. Ma Y., Pannicke U., Schwarz K., and Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108 (2002) 781-794
62. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., and de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105 (2001) 177-186
63. Riballo E., Kuhne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., and Löbrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 16 (2004) 715-724
64. Hoss M., Robins P., Naven T.J., Pappin D.J., Sgouros J., and Lindahl T. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J. 18 (1999) 3868-3875
65. Mazur D.J., and Perrino F.W. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3′ → 5′ exonucleases. J. Biol. Chem. 274 (1999) 19655-19660
66. Cooper M.P., Machwe A., Orren D.K., Brosh R.M., Ramsden D., and Bohr V.A. Ku complex interacts with and stimulates the Werner protein. Genes Dev. 14 (2000) 907-912
67. Yannone S.M., Roy S., Chan D.W., Murphy M.B., Huang S., Campisi J., and Chen D.J. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J. Biol. Chem. 276 (2001) 38242-38248
68. Moore J.K., and Haber J.E. Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae. Mol. Cell Biol. 16 (1996) 2164-2173
69. Chen L., Trujillo K., Ramos W., Sung P., and Tomkinson A.E. Promotion of Dnl4-catalyzed DNA end-joining by the Rad50/Mre11/Xrs2 and Hdf1/Hdf2 complexes. Mol. Cell 8 (2001) 1105-1115
70. Di Virgilio M., and Gautier J. Repair of double-strand breaks by nonhomologous end joining in the absence of Mre11. J. Cell Biol. 171 (2005) 765-771
71. Huang J., and Dynan W.S. Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction. Nucleic Acids Res. 30 (2002) 667-674
72. Paull T.T., and Gellert M. A mechanistic basis for Mre11-directed DNA joining at microhomologies. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6409-6414
73. Ding Q., Reddy Y.V., Wang W., Woods T., Douglas P., Ramsden D.A., Lees-Miller S.P., and Meek K. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol. Cell Biol. 23 (2003) 5836-5848
74. Henner W.D., Rodriguez L.O., Hecht S.M., and Haseltine W.A. Gamma-ray induced deoxyribonucleic acid strand breaks. 3′ glycolate termini. J. Biol. Chem. 258 (1983) 711-713
75. Bertoncini C.R., and Meneghini R. DNA strand breaks produced by oxidative stress in mammalian cells exhibit 3′-phosphoglycolate termini. Nucleic Acids Res. 23 (1995) 2995-3002
76. Hutchinson F. Chemical changes induced in DNA by ionizing radiation. Prog. Nucleic Acids Res. Mol. Biol. 32 (1985) 115-154
77. Ryan A.J., Squires S., Strutt H.L., and Johnson R.T. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res. 19 (1991) 3295-3300
78. Hsiang Y.H., Hertzberg R., Hecht S., and Liu L.F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260 (1985) 14873-14878
79. Jilani A., Ramotar D., Slack C., Ong C., Yang X.M., Scherer S.W., and Lasko D.D. Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3′-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J. Biol. Chem. 274 (1999) 24176-24186
80. Karimi-Busheri F., Daly G., Robins P., Canas B., Pappin D.J., Sgouros J., Miller G.G., Fakhrai H., Davis E.M., Le Beau M.M., and Weinfeld M. Molecular characterization of a human DNA kinase. J. Biol. Chem. 274 (1999) 24187-24194
81. Chappell C., Hanakahi L.A., Karimi-Busheri F., Weinfeld M., and West S.C. Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining. EMBO J. 21 (2002) 2827-2832
82. Inamdar K.V., Pouliot J.J., Zhou T., Lees-Miller S.P., Rasouli-Nia A., and Povirk L.F. Conversion of phosphoglycolate to phosphate termini on 3′ overhangs of DNA double-strand breaks by the human tyrosyl-DNA phosphodiesterase hTdpl. J. Biol. Chem. 276 (2002) 24323-24330
83. Demple B., and Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Ann. Rev. Biochem. 63 (1994) 915-948
84. Suh D., Wilson III D.M., and Povirk L.F. 3′-Phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res. 25 (1997) 2495-2500
85. Chaudhry M.A., Dedon P.C., Wilson D.M., Demple B., and Weinfeld M. Removal by human apurinic/apyrimidinic endonuclease 1 (Ape 1) and Escherichia coli exonuclease III of 3′-phosphoglycolates from DNA treated with neocarzinostatin, calicheamicin, and gamma-radiation. Biochem. Pharmacol. 57 (1999) 531-538
86. Inamdar K.V., Yu Y., and Povirk L.F. Resistance of 3′-phosphoglycolate DNA ends to digestion by mammalian DNase III. Radiat. Res. 157 (2002) 306-311
87. Interthal H., Pouliot J.J., and Champoux J.J. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12009-12014
88. Takashima H., Boerkoel C.F., John J., Saifi G.M., Salih M.A., Armstrong D., Mao Y., Quiocho F.A., Roa B.B., Nakagawa M., Stockton D.W., and Lupski J.R. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 32 (2002) 267-272
89. Plo I., Liao Z.Y., Barcelo J.M., Kohlhagen G., Caldecott K.W., Weinfeld M., and Pommier Y. Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions. DNA Repair 2 (2003) 1087-1100
90. Zhou T., Lee J.W., Tatavarthi H., Lupski J.R., Valerie K., and Povirk L.F. Deficiency in 3′-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res. 33 (2005) 289-297
91. El-Khamisy S.F., Saifi G.M., Weinfeld M., Johansson F., Helleday T., Lupski J.R., and Caldecott K.W. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434 (2005) 108-113
92. Wang J., Pluth J.M., Cooper P.K., Cowan M.J., Chen D.J., and Yannone S.M. Artemis deficiency confers a DNA double-strand break repair defect and Artemis phosphorylation status is altered by DNA damage and cell cycle progression. DNA Repair 4 (2005) 556-570
93. Rooney S., Alt F.W., Lombard D., Whitlow S., Eckersdorff M., Fleming J., Fugmann S., Ferguson D.O., Schatz D.G., and Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med. 197 (2003) 553-565
94. Yang S.W., Burginjr A.B., Huizenga B.N., Robertson C.A., Yao K.C., and Nash H.A. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11534-11539
95. Barthelmes H.U., Habermeyer M., Christensen M.O., Mielke C., Interthal H., Pouliot J.J., Boege F., and Marko D. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II. J. Biol. Chem. 279 (2004) 55618-55625
96. Valerie K., and Povirk L.F. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22 (2003) 5792-5812
97. Calsou P., Delteil C., Frit P., Drouet J., and Salles B. Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J. Mol. Biol. 326 (2003) 93-103
98. Meek K., Gupta S., Ramsden D.A., and Lees-Miller S.P. The DNA-dependent protein kinase: the director at the end. Immunol. Rev. 200 (2004) 132-141
99. Hsu H.-L., Yannone S.M., and Chen D.J. Defining the interactions between DNA-PK and ligase IV/XRCC4. DNA Repair 1 (2001) 225-235
100. Calsou P., Frit P., Humbert O., Muller C., Chen D.J., and Salles B. The DNA-dependent protein kinase catalytic activity regulates DNA end processing by means of Ku entry into DNA. J. Biol. Chem. 274 (1999) 7848-7856
101. Lee J.W., Inamdar K.V., Hannah M.F., Lees-Miller S.P., and Povirk L.F. DNA end sequestration by DNA-dependent protein kinase and joining of sterically constrained substrates in whole-cell extracts. Environ. Mol. Mutagen. 42 (2003) 279-287
102. Reddy Y.V., Ding Q., Lees-Miller S.P., Meek K., and Ramsden D.A. Non-homologous end joining requires that the DNA-PK complex undergo an autophosphorylation-dependent rearrangement at DNA ends. J. Biol. Chem. 279 (2004) 39408-39413
103. DeFazio L.G., Stansel R.M., Griffith J.D., and Chu G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J. 21 (2002) 3192-3200
104. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
105. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., and Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404 (2000) 510-514
106. Löbrich M., Rydberg B., and Cooper P.K. Repair of X-ray-induced DNA double-strand breaks in specific NotI restriction fragments in human fibroblasts: joining of correct and incorrect ends. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12050-12054
107. Wang H., Perrault A.R., Takeda Y., Qin W., and Iliakis G. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res. 31 (2003) 5377-5388
108. Karanjawala Z.E., Grawunder U., Hsieh C.L., and Lieber M.R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9 (1999) 1501-1504
109. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., and Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404 (2000) 897-900
110. Verkaik N.S., Esveldt-van Lange R.E., van Heemst D., Bruggenwirth H.T., Hoeijmakers J.H., Zdzienicka M.Z., and van Gent D.C. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur. J. Immunol. 32 (2002) 701-709
111. Audebert M., Salles B., and Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem. 279 (2004) 55117-55126
112. Kalish J.M., Seidman M.M., Weeks D.L., and Glazer P.M. Triplex-induced recombination and repair in the pyrimidine motif. Nucleic Acids Res. 33 (2005) 3492-3502
113. Datta K., Neumann R.D., and Winters T.A. Characterization of a complex 125I-induced DNA double-strand break: implications for repair. Int. J. Radiat. Biol. 81 (2005) 13-21